ATTERX BIOTHERAPEUTICS
Atterx is developing fundamentally new therapeutics to combat the growing epidemic of antibiotic-resistant bacteria. Antibiotic resistance is a medical crisis, globally responsible for hundreds of thousands of deaths each year. ConjuGon's core technology is a new way to kill unwanted and even multi-drug resistant bacteria. The company is located in the MG&E Innovation Center in the University Research Park in Madison, Wisconsin.
ATTERX BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2001-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.atterx.com
Total Employee:
1+
Status:
Active
Contact:
6084412891
Email Addresses:
[email protected]
Total Funding:
6.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF LetsEncrypt WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail AJAX Libraries API
Similar Organizations
AkaRx
AkaRx develops therapeutics including the orally-available small molecule for use in the treatment of thrombocytopenia.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Atterx Biotherapeutics
Rosetta Partners
Rosetta Partners investment in Venture Round - Atterx Biotherapeutics
Wisconsin Investment Partners
Wisconsin Investment Partners investment in Venture Round - Atterx Biotherapeutics
Official Site Inspections
http://www.atterx.com Semrush global rank: 6.1 M Semrush visits lastest month: 1.33 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
